Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

Net profit of Neuland Laboratories rose 166.42% to Rs 81.39 crore in the quarter ended December 2023 as against Rs 30.55 crore during the previous quarter ended December 2022. Sales rose 45.90% to Rs 392.83 crore in the quarter ended December 2023 as against Rs 269.25 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales392.83269.25 46 OPM %30.8720.09 - PBDT119.6252.27 129 PBT104.4838.94 168 NP81.3930.55 166 Powered by Capital Market - Live News

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Neuland Laboratories has appointed Dr. Sharadsrikar V. Kotturi as Chief Scientific Officer (CSO) w.e.f. 22 November 2023.Powered by Capital Market - Live News

Net profit of Neuland Laboratories rose 132.06% to Rs 89.25 crore in the quarter ended September 2023 as against Rs 38.46 crore during the previous quarter ended September 2022. Sales rose 42.23% to Rs 417.75 crore in the quarter ended September 2023 as against Rs 293.71 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales417.75293.71 42 OPM %32.9123.59 - PBDT136.1066.36 105 PBT121.5953.19 129 NP89.2538.46 132 Powered by Capital Market - Live News